AusCann Joint Venture Harvests Second Crop in Chile Highlights...

AusCann Joint Venture Harvests Second Crop in Chile Highlights Australia
• AusCann’s Chilean JV DayaCann has completed its second harvest
• The harvest yielded 620kg of dried cannabis buds, an increase from last year’s crop
• The yield will be used for Chilean patients and potential export
• Patients in Chile’s new special access scheme are being supplied DayaCann cannabis
• AusCann sees significant potential in the South American market following recent regulatory changes in the region

Thursday 07 June 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8)

(AusCann or ‘the Company’) is pleased to announce that it has completed its second harvest with DayaCann joint venture partner Fundación Daya in Chile. The second crop yielded 620kg of dried cannabis product, an increase of over 50 per cent on the 400kg yielded from the first crop. This equates to an approximate yield of 1.2 tonnes per Hectare. DayaCann has a total 30-hectare facility in the south of Santiago which features an open greenhouse to grow various strains for particular cannabinoid profiles. DayaCann planted the second crop at the end of 2017 using the superior strains selected from the first crop. Fundación Daya has worked with the Chilean National Institute of Public Health to establish a special access scheme (SAS) similar to the one in Australia which enables patients in Chile access to local medicinal cannabis product. The medical cannabis product in Chile’s SAS is being locally manufactured at Knop Laboratories from cannabis supplied by DayaCann. AusCann sees the South American market as internationally significant following recent legislative changes in Argentina, which has joined Chile, Colombia and Uruguay in legalising medical cannabis for therapeutic purposes.